ICD-10-CM Code D68.318

Valid for Submission

D68.318 is a billable code used to specify a medical diagnosis of other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code D68.318 might also be used to specify conditions or terms like drug-induced coagulation inhibitor disorder, factor i inhibitor disorder, hemorrhagic disorder due to antithrombinemia, hemorrhagic disorder due to circulating anticoagulants, hemorrhagic disorder due to increase in anti-11a, hemorrhagic disorder due to increase in anti-8a, etc

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D68.318:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

• Antithromboplastinemia
• Antithromboplastinogenemia
• Hemorrhagic disorder due to intrinsic increase in antithrombin
• Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
• Hemorrhagic disorder due to intrinsic increase in anti-IXa
• Hemorrhagic disorder due to intrinsic increase in anti-XIa

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D68.318 are found in the index:

• - Anticoagulant, circulating (intrinsic) - See Also: - Disorder, hemorrhagic; - D68.318

• - Antithromboplastinemia - D68.318

• - Antithromboplastinogenemia - D68.318

• - Circulating anticoagulants - See Also: - Disorder, hemorrhagic; - D68.318

• - Disorder (of) - See Also: Disease;
  • - hemorrhagic NEC - D69.9
    • - due to
      • - intrinsic
        • - circulating anticoagulants - D68.318
        • - increase in
          • - antithrombin - D68.318
          • - anti-VIIIa - D68.318
          • - anti-IXa - D68.318
          • - anti-XIa - D68.318

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Drug-induced coagulation inhibitor disorder
• Factor I inhibitor disorder
• Hemorrhagic disorder due to antithrombinemia
• Hemorrhagic disorder due to circulating anticoagulants
• Hemorrhagic disorder due to increase in anti-11a
• Hemorrhagic disorder due to increase in anti-8a
• Hemorrhagic disorder due to increase in anti-9a

Convert D68.318 to ICD-9

• 286.59 - Ot hem d/t circ anticoag

Code Classification

• Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
  • Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
    • Other coagulation defects (D68)

Code History

• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
  (First year ICD-10-CM implemented into the HIPAA code set)
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Tools

• Copy Code
• Copy Description
• View Related Codes
• Convert D68.318 to ICD-9